Guided Therapeutics (GTHP) Change in Inventory (2016 - 2025)

Guided Therapeutics' Change in Inventory history spans 14 years, with the latest figure at -$135000.0 for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 4400.0% to -$135000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$185000.0, a 18600.0% decrease, with the full-year FY2025 number at -$185000.0, down 18600.0% from a year prior.
  • Change in Inventory hit -$135000.0 in Q4 2025 for Guided Therapeutics, down from -$12000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for GTHP hit a ceiling of $74000.0 in Q3 2023 and a floor of -$135000.0 in Q4 2025.
  • Historically, Change in Inventory has averaged -$4411.8 across 5 years, with a median of -$1000.0 in 2021.
  • Biggest five-year swings in Change in Inventory: skyrocketed 6000.0% in 2023 and later tumbled 4400.0% in 2025.
  • Tracing GTHP's Change in Inventory over 5 years: stood at -$47000.0 in 2021, then surged by 170.21% to $33000.0 in 2022, then crashed by 145.45% to -$15000.0 in 2023, then surged by 80.0% to -$3000.0 in 2024, then tumbled by 4400.0% to -$135000.0 in 2025.
  • Business Quant data shows Change in Inventory for GTHP at -$135000.0 in Q4 2025, -$12000.0 in Q3 2025, and -$38000.0 in Q2 2025.